© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
March 21, 2018
Biosimilars for rituximab, trastuzumab, and bevacizumab are currently approved for use in the European Union.
January 22, 2018
Cetuximab (Erbitux) with pembrolizumab (Keytruda) shows promise in patients with mCRC.
January 19, 2018
A combination VEGFR-2 inhibitor plus an antiâ€“PD-L1 agent demonstrated antitumor activity in patients with previously treated advanced gastric or gastroesophageal junction adenocarcinoma.